Loading...
Escalating Payer Pressures Will Crush Margins Despite Fleeting Pipeline Optimism
AnalystLowTarget's Fair Value
US$43.00
59.1% overvalued intrinsic discount04 Sep
US$68.40
1Y
80.9%7D
8.6%1Y
80.9%7D
8.6%You can edit this narrative until Aug 5 10:30 PM. Then, changes will post as Updates.